Organic Chemistry TRIZ Cases

A low-molecular-weight fused polycyclic heteroaromatic compound enables high charge mobility through a compact planar structure.

A thiadiazole corrosion inhibitor composition incorporating a solubility enhancing component to maintain stability in base oils.

Quinone-based nitric oxide donor compounds replace traditional nitrates to eliminate tolerance and side effects while maintaining vasodilating efficacy.

Bicyclic triazolo-azepine derivatives selectively inhibit gamma-secretase to lower Aβ42 levels while preserving essential Notch signaling pathways.

Novel oxazoline pseudodimer compounds act as trace amine-associated receptor 1 agonists to provide targeted pain relief.

Placing heating elements inside a central duct simplifies the tube bundle, reduces flange complexity, and cuts maintenance downtime.

Dynamic switching control in a SEPIC converter eliminates electrolytic capacitors to extend component lifetime while maintaining high power factor.

A pentaerythritol ester plasticizer reduces migration and volatility in polyvinylchloride compositions.

Solvent-free three-component reaction achieves >90% yield and reproducible isomer ratios by optimizing molar ratios and vacuum distillation.

Fluorinated ascochlorin derivatives resolve low solubility and metabolic instability in AMPK activators.

Formula I pyrrolo[3,2-d]pyrimidine compounds inhibit USP1 to overcome potency and off-target limitations of existing small molecule inhibitors.

Alicyclic photoresist polymers with acid-labile and ether groups reduce material migration, enabling fine pattern formation without a topcoat layer.

Fusing a cycloalkane to a polycyclic aromatic hydrocarbon core reduces intermolecular interactions, improving color purity and device lifespan.

Novel pyridone derivatives inhibit HIV integrase to treat resistant strains while reducing side effects.

Benzindenofluorenyl derivatives achieve deep-blue emission with narrow spectra, resolving the trade-off between color purity and device lifetime in OLEDs.

Limiting by-products with molecular weight 650-670 in the color-developing agent reduces background fogging under moist heat and plasticizer exposure.

Formula I compounds inhibit CDK7 activity to treat proliferative diseases while overcoming structural similarity among CDK family members.

Segmented purine structures provide selective PI3K-delta inhibition to resolve treatment effectiveness versus therapy availability trade-offs.

An upflow reactor distributor uses angled perforations to dissipate reactant momentum against the vessel wall.

Hydrophilic monomers form interchain hydrogen bonds to boost protein binding, minimizing capacity loss when combined with ion exchange units.

Small molecule pyrazoles enable oral administration and cost-effective manufacturing while selectively activating the follicle-stimulating hormone receptor.

Novel polymeric compound with acid-labile groups improves pattern resolution while maintaining alkali solubility under acid action.

Fluorinated benzimidazole derivatives improve chemical stability and lipophilicity, enabling effective blood-brain barrier penetration for glioma treatment.

One-pot condensation eliminates delicate hydrolysis and protection steps to boost Lifitegrast purity.

Formula I compounds stabilize free radicals in propellant grain matrices to control combustion speed, replacing toxic dinitrotoluene with safer alternatives.

Imidazolium fluorescent molecules enable real-time neutron and gamma radiation discrimination through rapid optical emission.

C2-symmetric ONNN ligands direct metal centers to resolve stereochemical control and reactivity contradictions in racemic lactide polymerization.

Non-polymeric compounds with acid-labile groups enhance photoresist sensitivity while reducing unexposed film thickness loss.

Transition metal catalyzes oxidation of specific compound to scavenge oxygen while maintaining transparency without haze or crystallization issues.

A biphenyl derivative resist bottom layer material provides etch resistance and solvent stability through specific chemical structures.

Imidazothienopyridine compounds serve as targeted pharmaceutical agents for oncology applications.

A polymer compound with specific repeating units enhances triplet excited state energy levels and conductive properties.

Fluorinated substituents enhance metabolic stability while minimizing cytochrome P450 inhibition and hERG channel blockade.

Specific tetraaryl-phenylene diamine matrices reduce operating voltage and improve efficiency by optimizing charge balance in phosphorescent OLED devices.

Cleavable prodrug linkers transport noribogaine across the blood-brain barrier, increasing brain concentration while reducing systemic side effects.

Tandem mass spectrometry quantifies alpha-L-iduronidase enzymatic activity using organic solvent extraction and internal standards.

Direct alcohol-to-thiol conversion eliminates hazardous trifluoromethanesulfonic anhydride, reducing waste streams and operational costs.

Isoquinoline amide compounds act as allosteric potentiators of the mGluR4 receptor to enhance neural signaling pathways.

Hybrid triazine-phenazine compounds resolve synthesis complexity trade-offs to achieve high external quantum efficiency exceeding 20%.

Thermal palladium(0) powder in a hydrogen atmosphere activates the surface, enabling room temperature salt production without external heating.

A novel dicarboxylic acid compound inhibits active phosphate transport in the digestive tract to reduce phosphorus absorption.